EX-25.1 7 exh_251.htm EXHIBIT 25.1 exh_251.htm
EXHIBIT 25.1

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM T-1
STATEMENT OF ELIGIBILITY
UNDER THE TRUST INDENTURE ACT OF 1939 OF A
CORPORATION DESIGNATED TO ACT AS TRUSTEE
CHECK IF AN APPLICATION TO DETERMINE
ELIGIBILITY OF A TRUSTEE PURSUANT TO
SECTION 305(b)(2)
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
(Exact name of trustee as specified in its charter)
     
 
(State of incorporation
if not a U.S. national bank)
 
95-3571558
(I.R.S. employer
identification no.)

     
700 South Flower Street
Suite 500
Los Angeles, California
(Address of principal executive offices)
 
 
 
90017
(Zip code)
Evelyn T. Furukawa
700 South Flower Street, Suite 500
Los Angeles, California 90017
213.630.6463
(Name, address and telephone number of agent for service)
GLOBAL GEOPHYSICAL SERVICES INC.
 (Exact name of obligor as specified in its charter)
 
     
Delaware
(State or other jurisdiction of
incorporation or organization)
 
05-0574281
(I.R.S. employer
identification no.)

     
13927 South Gessner Road
Missouri City, Texas
(Address of principal executive offices)
 
 
77489
(Zip code)
     
 
 
Debt Securities
(Title of the Indenture Securities)

 
 

 
1.
General information. Furnish the following information as to the trustee:
 
(a)
Name and address of each examining or supervising authority to which it is subject.

     
Name
 
Address
 
Comptroller of the Currency
United States Department of the Treasury
 
Washington, D.C. 20219
     
Federal Reserve Bank
 
San Francisco, California 94105
     
Federal Deposit Insurance Corporation
 
Washington, D.C. 20429
 
  (b)  Whether it is authorized to exercise corporate trust powers.
     
  Yes.  
 
2.
Affiliations with Obligor.
     
 
If the obligor is an affiliate of the trustee, describe each such affiliation.
     
 
None.

3-15.
Not applicable.
     
16.
List of Exhibits.
     
 
Exhibits identified in parentheses below, on file with the Commission, are incorporated herein by reference as an exhibit hereto, pursuant to Rule 7a-29 under the Trust Indenture Act of 1939 (the “Act”) and 17 C.F.R. 229.10(d).
 
 
 

 
 
 
1.
 
A copy of the articles of association of The Bank of New York Mellon Trust Company, N.A. (Exhibit 1 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-121948 and Exhibit 1 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 No. 333-152875).
       
 
2.
 
A copy of certificate of authority of the trustee to commence business. (Exhibit 2 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-121948).
       
 
3.
 
A copy of the authorization of the trustee to exercise corporate trust powers. (Exhibit 3 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-152875).
       
 
4.
 
A copy of the existing by-laws of the trustee. (Exhibit 4 to Form T-1 filed as Exhibit 25.1 to the Registration Statement on Form S-3 File No. 333-152875).
       
 
6.
 
The consent of the trustee required by Section 321(b) of the Act.
       
 
7.
 
A copy of the latest report of condition of the trustee published pursuant to law or to the requirements of its supervising or examining authority.
 
 
 
 

 
SIGNATURE
     Pursuant to the requirements of the Act, the trustee, The Bank of New York Mellon Trust Company, N.A., a banking association organized and existing under the laws of the United States of America, has duly caused this statement of eligibility to be signed on its behalf by the undersigned, thereunto duly authorized, all in The City of Los Angeles, and State of California, on the 26th day of July, 2012.

         
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
 
 
  By: /s/ Teresa Petta  
   
Name:
Teresa Petta  
   
Title:
Vice President
 
 
 
 
 

 
EXHIBIT 6
CONSENT OF THE TRUSTEE
 
 
Pursuant to the requirements of Section 321 (b) of the Trust Indenture Act of 1939, and in connection with the proposed issue of Global Geophysical Services, Inc., The Bank of New York Mellon Trust Company, N.A. hereby consents that reports of examinations by Federal, State, Territorial or District authorities may be furnished by such authorities to the Securities and Exchange Commission upon request therefore.

         
 
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
 
 
  By: /s/ Teresa Petta  
       
       
 
Los Angeles, California
July 26, 2012

 
 

 
EXHIBIT 7
Consolidated Report of Condition of
THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
of 400 South Hope Street, Suite 400, Los Angeles, CA 90071

At the close of business March 31, 2012, published in accordance with Federal regulatory authority instructions.                                                                                                                         
                       

     Dollar Amounts  
     in Thousands  
ASSETS
     
       
Cash and balances due from
depository institutions:
     
Noninterest-bearing balances and currency and coin
    802  
Interest-bearing balances
    401  
Securities:
       
Held-to-maturity securities
    0  
Available-for-sale securities
    622,734  
Federal funds sold and securities
purchased under agreements to resell:
       
Federal funds sold
    78,500  
Securities purchased under agreements to resell
    0  
Loans and lease financing receivables:
       
Loans and leases held for sale
    0  
Loans and leases, net of unearned income
    0  
LESS: Allowance for loan and lease losses
    0  
Loans and leases, net of unearned income and allowance
    0  
Trading assets
    0  
Premises and fixed assets (including capitalized leases)
    7,193  
Other real estate owned
    0  
Investments in unconsolidated
subsidiaries and associated
companies
    1  
Direct and indirect investments in real estate ventures
    0  
Intangible assets:
       
      Goodwill
    856,313  
      Other intangible assets
    180,552  
Other assets
    123,965  
Total assets
  $ 1,870,461  
 
 
1

 
LIABILITIES
     
       
Deposits:
     
       In domestic offices
    504  
Noninterest-bearing
    504  
Interest-bearing
    0  
       Not applicable
       
Federal funds purchased and securities
sold under agreements to repurchase:
       
Federal funds purchased
    0  
Securities sold under agreements to repurchase
    0  
Trading liabilities
    0  
Other borrowed money:
       
(includes mortgage indebtedness and obligations under capitalized leases)
    0  
Not applicable
       
Not applicable
       
Subordinated notes and debentures
    0  
Other liabilities
    226,926  
Total liabilities
    227,430  
Not applicable
       
         
EQUITY CAPITAL
       
         
Perpetual preferred stock and related surplus
    0  
Common stock
    1,000  
Surplus (exclude all surplus related to preferred stock)
    1,121,520  
Not available
       
   Retained earnings
    515,960  
   Accumulated other comprehensive income
    4,551  
Other equity capital components
    0  
Not available
       
    Total bank equity capital
    1,643,031  
    Noncontrolling (minority) interests in consolidated subsidiaries
    0  
Total equity capital
    1,643,031  
Total liabilities and equity capital
    1,870,461  

I, Karen Bayz, CFO and Managing Director of the above-named bank do hereby declare that the Reports of Condition and Income (including the supporting schedules) for this report date have been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and are true to the best of my knowledge and belief.

Karen Bayz                                )           CFO and Managing Director

We, the undersigned directors (trustees), attest to the correctness of the Report of Condition (including the supporting schedules) for this report date and declare that it has been examined by us and to the best of our knowledge and belief has been prepared in conformance with the instructions issued by the appropriate Federal regulatory authority and is true and correct.

Troy Kilpatrick, President                                                              )
Frank P. Sulzberger, MD                                                               )           Directors (Trustees)
William D. Lindelof, MD                                                               )
 
 
2